IP Library Granted Patent US 8,999,961
Granted Patent B2
US 8,999,961 · App. 13/946,418 · Granted Apr 7, 2015

Pharmaceutical formulation containing gelling agent

Inventors: Curtis Wright (Rockport, MA); Benjamin Oshlack (Boca Raton, FL); Christopher Breder (Greenwich, CT)
Assignees: Purdue Pharma, L.P.; The P.F. Laboratories, Inc.; Purdue Pharmaceuticals L.P.
A61K31/167A61K9/2013A61K9/205A61K9/2054A61K9/0002A61K31/439A61K31/485A61K47/38A61K47/36A61K47/10A61K45/06A61K31/192A61K9/1652A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,999,961
App. No.
13/946,418
Granted
Apr 7, 2015
Kind
B2
Abstract

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Claims (14)

1. An immediate release oral dosage form comprising:

a mixture of (i) a therapeutically effective amount of oxycodone hydrochloride; (ii) a gelling agent comprising xanthan gum, the gelling agent in an effective amount to impart a viscosity of at least about 10 cP to a solubilized mixture formed when the dosage form is subject to tampering by dissolution in from about 0.5 to about 10 ml of an aqueous liquid; and (iii) an effective amount of an irritant to impart an irritating or burning sensation upon administration of a tampered dosage form;

wherein the weight ratio of the xanthan gum to the oxycodone hydrochloride is from about 1:8 to about 8:1; and

wherein the dosage form is in the form of a tablet and provides an immediate release of the oxycodone hydrochloride when the dosage form is orally administered to a human patient.

2. The immediate release oral dosage form of claim 1 , wherein the aqueous liquid is water.

3. The immediate release oral dosage form of claim 1 , wherein the viscosity is attained when about 1 to about 3 ml of aqueous liquid is mixed with the dosage form.

4. The immediate release oral dosage form of claim 1 , wherein the solubilized mixture has a viscosity of at least about 60 cP.

5. The immediate release oral dosage form of claim 1 , wherein the solubilized mixture has a viscosity of 120 cP or greater.

6. The immediate release oral dosage form of claim 1 , wherein the solubilized mixture has a viscosity of from 120 cP to 5,000 cP.

7. An immediate release oral dosage form comprising:

a mixture of (i) a therapeutically effective amount of oxycodone hydrochloride; and (ii) a gelling agent comprising xanthan gum, the gelling agent in an effective amount to impart a viscosity of 120 cP or greater to a solubilized mixture formed when the dosage form is subject to tampering by dissolution in from about 0.5 to about 10 ml of an aqueous liquid;

wherein the weight ratio of the xanthan gum to the oxycodone hydrochloride is from about 1:8 to about 8:1; and

wherein the dosage form is in the form of a tablet and provides an immediate release of the oxycodone hydrochloride when the dosage form is orally administered to a human patient.

8. The immediate release oral dosage form of claim 7 , wherein the solubilized mixture has a viscosity of from 120 cP to 5,000 cP.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2019
From: THE P.F. LABORATORIES, INC.; PURDUE PHARMA TECHNOLOGIES, INC.
To: PURDUE PHARMA L.P.
Reel/Frame 048932/0651 →
Continuity (6)
Continuation 13890874 · May 9, 2013
Continuation 13765368 · Feb 12, 2013
Continuation 12262015 · Oct 30, 2008
Continuation 10214412 · Aug 6, 2002
Provisional Application 60310534 · Aug 6, 2001
Related Publication 20130303494A1 · Nov 14, 2013